Clinical Trial Update: Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)

View source ↗

Summary

A clinical study investigates membrane polyunsaturated fatty acid content in fibromyalgia and systemic lupus erythematosus. The current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia
• Systemic Lupus Erythematosus

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Fibromyalgia, Systemic Lupus Erythematosus | Status: UNKNOWN